Fludarabine Therapy in Macroglobulinemic Lymphoma

Blood - United States
doi 10.1182/blood.v75.10.1928.1928
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Fludarabine and Busulfan Versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Use of Fludarabine for the Treatment of Indolent Lymphoma With Chylothorax

Klinicka Onkologie
Oncology
2018English

Treatment of Relapsed Extranodal Natural Killer/T-Cell Lymphoma With Bortezomib Plus Fludarabine

Molecular and Clinical Oncology
Cancer ResearchOncology
2017English

Checkpoint Blockade Therapy Resistance in Hodgkin's Lymphoma

The Lancet
Medicine
2018English

Advances in Targeted Therapy for Malignant Lymphoma

Signal Transduction and Targeted Therapy
Cancer ResearchGenetics
2020English

Ibrutinib Therapy for Lymphoplasmacytic Lymphoma

American Journal of Hematology
Hematology
2017English

Myeloablative Doses of Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation in Non-Hodgkin'S Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Fludarabine Add-On Therapy in Interferon-Beta-Treated Patients With Multiple Sclerosis Experiencing Breakthrough Disease

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2016English

Consolidation Therapy for Follicular Lymphoma

European Oncology and Haematology
OncologyHematology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy